INS and Hypoglycemia: Despite a history of severe hypoglycemia, which was managed with rituximab and resolved within a month, and the presence of elevated insulin and insulin autoantibodies, she successfully completed ovarian stimulation without experiencing hypoglycemic episodes.<h4>Discussion</h4>Close monitoring of glucose levels and insulin autoantibody concentrations was essential for successful oocyte retrieval.